• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Valeant Pharmaceuticals International

Valeant Pharmaceuticals International

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  1. Valeant is being sued under racketeering law over drug price hikes

    Valeant is being sued under racketeering law over drug price hikes

  2. UPDATE: Valeant expected to name Paul Herendeen new CFO

    UPDATE: Valeant expected to name Paul Herendeen new CFO

  3. UPDATE: U.S. stocks pressured as mood turns cautious ahead of Yellen speech

    UPDATE: U.S. stocks pressured as mood turns cautious ahead of Yellen speech

  4. MARKET SNAPSHOT: U.S. Stocks Pressured As Mood Turns Cautious Ahead Of Yellen Speech

    MARKET SNAPSHOT: U.S. Stocks Pressured As Mood Turns Cautious Ahead Of Yellen Speech

  5. UPDATE: Valeant names Paul Herendeen as its new CFO

    UPDATE: Valeant names Paul Herendeen as its new CFO

  6. UPDATE: U.S. stocks flat as investors dither ahead of Yellen speech

    UPDATE: U.S. stocks flat as investors dither ahead of Yellen speech

  7. MARKET SNAPSHOT: S&P 500, Dow Industrials Book A Loss As Oil Snaps Win Streak

    MARKET SNAPSHOT: S&P 500, Dow Industrials Book A Loss As Oil Snaps Win Streak

  8. UPDATE: S&P 500, Dow industrials book a loss as oil snaps win streak

    UPDATE: S&P 500, Dow industrials book a loss as oil snaps win streak

  9. UPDATE: U.S. stocks retreat as sentiment cautious ahead of Yellen speech

    UPDATE: U.S. stocks retreat as sentiment cautious ahead of Yellen speech

  10. UPDATE: Valeant's stock soars as investors cheer poaching of Zoetis CFO

    UPDATE: Valeant's stock soars as investors cheer poaching of Zoetis CFO

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.